Basic info
Industry
biotechnology research
Sectors
autoimmune diseases
human genetics
Parkinson's disease
ankylosing spondylitis
inflammatory diseases
IBD
Crohn's disease
Pharmaceutical
neurological diseases
neurodegenerative diseases
Health Care
data science
neuroinflammatory diseases
psoriasis
precision medicine
Medical
immunological diseases
Ulcerative colitis
biotech
Date founded
2018
Funding rounds raised
Total raised
$100M
from 17 investors over 17 rounds
N
Neuron23 Inc. raised $100M on March 30, 2022
Investors: HBM Partners AG, SoftBank Investment Advisers, Acorn Bioventures, Westlake Village BioPartners®, Perceptive Advisors, Surveyor Capital, Kleiner Perkins and Redmile Group
N
Neuron23 Inc. raised $80M on December 16, 2020
Investors: Kleiner Perkins, Surveyor Capital, Perceptive Advisors, Westlake Village BioPartners®, HBM Partners AG, Acorn Bioventures and Redmile Group
N
Neuron23 Inc. raised $34M on December 16, 2020
Investors: Kleiner Perkins and Westlake Village BioPartners®